VHCP Management as of Dec. 31, 2016
Portfolio Holdings for VHCP Management
VHCP Management holds 21 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dbv Technologies (DBVTF) | 33.5 | $31M | 457k | 68.13 | |
| Heron Therapeutics (HRTX) | 15.4 | $14M | 1.1M | 13.10 | |
| Coherus Biosciences (CHRS) | 9.2 | $8.6M | 306k | 28.15 | |
| BioCryst Pharmaceuticals (BCRX) | 7.9 | $7.3M | 1.2M | 6.33 | |
| Flamel Technologies | 5.6 | $5.2M | 500k | 10.39 | |
| Ra Pharmaceuticals | 3.8 | $3.5M | 233k | 15.19 | |
| Adverum Biotechnologies | 3.4 | $3.2M | 1.1M | 2.90 | |
| Lipocine | 3.4 | $3.1M | 850k | 3.68 | |
| Colucid Pharmaceuticals | 2.7 | $2.5M | 68k | 36.40 | |
| Axovant Sciences | 2.5 | $2.3M | 184k | 12.42 | |
| Ocera Therapeutics | 2.1 | $1.9M | 912k | 2.10 | |
| Ascendis Pharma A S (ASND) | 2.0 | $1.8M | 90k | 20.24 | |
| Edge Therapeutics | 1.8 | $1.7M | 135k | 12.50 | |
| D Stemline Therapeutics | 1.6 | $1.4M | 135k | 10.70 | |
| Alcobra | 1.5 | $1.4M | 659k | 2.10 | |
| ARCA biopharma | 1.4 | $1.3M | 462k | 2.85 | |
| Akari Therapeutics | 1.2 | $1.1M | 158k | 7.04 | |
| Cytomx Therapeutics (CTMX) | 0.8 | $706k | 64k | 11.00 | |
| Audentes Therapeutics | 0.3 | $274k | 15k | 18.27 | |
| Pronai Therapeutics | 0.1 | $84k | 56k | 1.50 | |
| Aeglea Biotherapeutics | 0.0 | $26k | 6.0k | 4.33 |
